| Schedule of assets and liabilities of discontinued operations |
Schedule of assets and liabilities of
discontinued operations
| |
| | |
| |
| | |
May 26, 2026 | | |
December 31, 2025 | |
| Assets | |
| | |
| |
| Cash | |
$ | - | | |
$ | 474 | |
| Restricted cash | |
| 38,493 | | |
| 36,892 | |
| Accounts receivable | |
| 3,136,960 | | |
| 3,223,334 | |
| Inventories | |
| 115,639 | | |
| 112,250 | |
| Other receivables | |
| 445,514 | | |
| 432,458 | |
| Advances to suppliers | |
| 862,425 | | |
| 837,152 | |
| Value-added tax receivable, current | |
| 2,104,253 | | |
| 2,104,252 | |
| Total current assets | |
| 6,703,284 | | |
| 6,746,812 | |
| Property, plant and equipment, net | |
| 16,318,564 | | |
| 16,313,249 | |
| Intangible assets, net | |
| 3,064,945 | | |
| 2,992,157 | |
| Value-added tax receivable, noncurrent | |
| 926,708 | | |
| 838,274 | |
| Total noncurrent assets | |
| 20,310,217 | | |
| 20,143,680 | |
| Total assets | |
$ | 27,013,501 | | |
$ | 26,890,492 | |
| Liabilities | |
| | | |
| | |
| Short-term bank loans | |
$ | 6,332,376 | | |
$ | 6,146,809 | |
| Accounts payable | |
| 1,493,786 | | |
| 1,450,012 | |
| Accrued expenses and other current liabilities | |
| 5,402,497 | | |
| 5,030,921 | |
| Deferred income, current | |
| 110,590 | | |
| 110,590 | |
| Total current liabilities | |
| 13,339,249 | | |
| 12,738,332 | |
| Deferred income, noncurrent | |
| 1,030,117 | | |
| 1,022,465 | |
| Long-term payable | |
| 945,807 | | |
| 960,835 | |
| Total noncurrent liabilities | |
| 1,975,924 | | |
| 1,983,300 | |
| Total liabilities | |
$ | 15,315,173 | | |
$ | 14,721,632 | |
|
| Schedule of income and expense of discontinued operations |
| Schedule of income and expense of discontinued operations | |
| | | |
| | |
| | |
Three Months Ended
June 30, 2026 | | |
Three Months Ended
June 30, 2025 | |
| Revenue | |
$ | - | | |
$ | 2,490,036 | |
| Cost of revenue | |
| - | | |
| 1,407,670 | |
| Selling, general and administrative expenses | |
| - | | |
| 115,419 | |
| Research and development expense | |
| - | | |
| 155,053 | |
| Interest income (expense), net | |
| - | | |
| (133,921 | ) |
| Other income | |
| - | | |
| 23,944 | |
| Operating income (loss) before CTA reclassification | |
| - | | |
| 701,917 | |
| CTA reclassification loss | |
| (46,206 | ) | |
| - | |
| Income (loss) from discontinued operations | |
$ | (46,206 | ) | |
$ | 701,917 | |
| | |
| | | |
| | |
| | |
Period Ended
May 26, 2026 | | |
Six Months Ended
June 30, 2025 | |
| Revenue | |
$ | - | | |
$ | 4,077,180 | |
| Cost of revenue | |
| - | | |
| 2,913,882 | |
| Selling, general and administrative expenses | |
| 734,324 | | |
| 377,768 | |
| Research and development expense | |
| - | | |
| 221,376 | |
| Interest expense | |
| 124,081 | | |
| 264,323 | |
| Other income, net | |
| 26,269 | | |
| 152,914 | |
| Operating income (loss) | |
| (832,136 | ) | |
| 452,745 | |
| CTA reclassification loss | |
| (46,206 | ) | |
| - | |
| Income (loss) from discontinued operations | |
$ | (878,342 | ) | |
$ | 452,745 | |
|